Related Experiment Videos
Mechanisms for macrophage-mediated HIV-1 induction
Krishnakumar Devadas1, Neil J Hardegen, Larry M Wahl
1Immunopathogenesis Section, Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA. devadas@cber.fda.gov
Journal of Immunology (Baltimore, Md. : 1950)
|November 24, 2004
Summary
Macrophages activate latent HIV-1 replication by inducing nuclear localization of NF-kappaB and proinflammatory cytokines. This interaction is crucial for viral reactivation in chronically infected cells.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Viral latency is a persistent challenge in HIV-1 infection.
- Understanding HIV-1 reactivation mechanisms is critical for therapeutic strategies.
Purpose of the Study:
- To elucidate the mechanism by which macrophages activate latent HIV-1 replication.
- To identify key molecular players involved in HIV-1 reactivation.
Main Methods:
- Coculture of macrophages with latently infected U1 or ACH2 cells.
- Analysis of NF-kappaB nuclear localization and cytokine expression using multiplexed RT-PCR.
- Inhibition studies using paraformaldehyde fixation, anti-TNF-alpha antibodies, and NF-kappaB inhibitors (BAY 11-7082).
Main Results:
- Macrophage interaction rapidly induced nuclear translocation of NF-kappaB p50/p65 dimer and increased expression of cytokines (IL-1beta, IL-6, IL-8, TNF-alpha, TGF-beta).
- Cell fixation abrogated NF-kappaB induction and HIV-1 replication, highlighting the necessity of cell-cell interaction.
- Neutralization of TNF-alpha and inhibition of NF-kappaB signaling significantly reduced HIV-1 replication.
Conclusions:
- Macrophage-mediated HIV-1 reactivation involves NF-kappaB signaling and induction of proinflammatory cytokines.
- Cooperative interaction between macrophages and infected cells is essential for triggering viral replication.
- Targeting NF-kappaB pathways may offer novel therapeutic approaches for managing HIV-1 latency.